1. Disease Areas
  2. Neurological, Eye or Ear Disease
  3. Neurodegenerative Disease
  4. Parkinson's Disease

Parkinson's Disease

Parkinsonism is characterized by bradykinesia plus at least one of the following: rest tremor, rigidity, or postural instability, and represents a clinical syndrome seen in various neurodegenerative disorders, including Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration, dementia with Lewy bodies (DLB), and Parkinson disease dementia (PDD), among others. While bradykinesia is the core feature across these conditions, patients often exhibit additional motor and nonmotor symptoms. The term "extrapyramidal" is outdated and imprecise, as it inaccurately implies involvement outside the pyramidal system, and its use is discouraged in scientific literature and movement disorder journals.

References:

Parkinson's Disease (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-15608
    MPTP hydrochloride 23007-85-4 99.82%
    MPTP hydrochloride is a brain penetrant dopaminergic neurotoxin. MPTP hydrochloride can be used to induce Parkinson’s Disease model. MPTP hydrochloride, a precusor of MPP+, induces apoptosis. MPTP hydrochloride has been verified by MCE with professional biological experiments.
    MPTP hydrochloride